Clinical Trials Browser

Unknown × Squamous Cell Carcinoma of Head and Neck × tremelimumab × Clear all

NCT03450967 2021-08-10

Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck